RALLYE SA (RAL.PA)

FR0000060618 - Common Stock

0.1074  +0 (+2.68%)

Fundamental Rating

2

Overall RAL gets a fundamental rating of 2 out of 10. We evaluated RAL against 30 industry peers in the Consumer Staples Distribution & Retail industry. RAL has a bad profitability rating. Also its financial health evaluation is rather negative. RAL does not seem to be growing, but still is valued expensively.



3

1. Profitability

1.1 Basic Checks

RAL had negative earnings in the past year.
In the past year RAL had a positive cash flow from operations.
In the past 5 years RAL always reported negative net income.
In the past 5 years RAL always reported a positive cash flow from operatings.

1.2 Ratios

RAL has negative profitability rations, so we won't be analyzing them here.
Measured over the past 3 years, the Average Return On Invested Capital for RAL is below the industry average of 7.86%.
The 3 year average ROIC (3.44%) for RAL is well above the current ROIC(%ROIC%%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)3.44%
ROIC(5y)3.37%

1.3 Margins

With an excellent Operating Margin value of 4.83%, RAL belongs to the best of the industry, outperforming 86.21% of the companies in the same industry.
RAL's Operating Margin has improved in the last couple of years.
RAL has a Gross Margin of 7.87%. This is amonst the worse of the industry: RAL underperforms 82.76% of its industry peers.
RAL's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.83%
PM N/A
GM 7.87%
OM growth 3Y9.77%
OM growth 5Y2.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.87%
GM growth 5Y1.82%

1

2. Health

2.1 Basic Checks

RAL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, RAL has more shares outstanding
The number of shares outstanding for RAL has been increased compared to 5 years ago.
Compared to 1 year ago, RAL has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.63, we must say that RAL is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.63, RAL is not doing good in the industry: 82.76% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.63
ROIC/WACCN/A
WACC3.68%

2.3 Liquidity

A Current Ratio of 0.92 indicates that RAL may have some problems paying its short term obligations.
The Current ratio of RAL (0.92) is better than 62.07% of its industry peers.
A Quick Ratio of 0.92 indicates that RAL may have some problems paying its short term obligations.
RAL has a better Quick ratio (0.92) than 86.21% of its industry peers.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.92

2

3. Growth

3.1 Past

The earnings per share for RAL have decreased strongly by -824.80% in the last year.
Looking at the last year, RAL shows a quite strong growth in Revenue. The Revenue has grown by 9.33% in the last year.
Measured over the past years, RAL shows a decrease in Revenue. The Revenue has been decreasing by -2.63% on average per year.
EPS 1Y-824.8%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-3989.22%
Revenue growth 1Y9.33%
Revenue growth 3Y-1.25%
Revenue growth 5Y-2.63%
Revenue growth Q2Q0%

3.2 Future

Based on estimates for the next years, RAL will show a very negative growth in Earnings Per Share. The EPS will decrease by -47.78% on average per year.
RAL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.56% yearly.
EPS Next Y-198.48%
EPS Next 2Y-76.24%
EPS Next 3Y-47.78%
EPS Next 5YN/A
Revenue Next Year7.51%
Revenue Next 2Y8.28%
Revenue Next 3Y7.56%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RAL. In the last year negative earnings were reported.
Also next year RAL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, RAL is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.41

4.3 Compensation for Growth

A cheap valuation may be justified as RAL's earnings are expected to decrease with -47.78% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-76.24%
EPS Next 3Y-47.78%

0

5. Dividend

5.1 Amount

No dividends for RAL!.
Industry RankSector Rank
Dividend Yield N/A

RALLYE SA

EPA:RAL (9/29/2023, 7:00:00 PM)

0.1074

+0 (+2.68%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.68M
Analysts40
Price Target0.1 (-6.89%)
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)-8.41%
DP-0.33%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
PT rev (1m)0%
PT rev (3m)-81.82%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-238.3%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.48%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0
P/FCF N/A
P/OCF 0.03
P/B N/A
P/tB N/A
EV/EBITDA 1.41
EPS(TTM)-45.5
EYN/A
EPS(NY)-0.74
Fwd EYN/A
FCF(TTM)-28
FCFYN/A
OCF(TTM)3.19
OCFY2973.18%
SpS337.85
BVpS-58.42
TBVpS-58.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE -44.35%
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 4.83%
PM N/A
GM 7.87%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)3.44%
ROIC(5y)3.37%
ROICexc(3y)3.95%
ROICexc(5y)3.96%
ROICexgc(3y)9.21%
ROICexgc(5y)9.53%
ROCE(3y)4.68%
ROCE(5y)4.59%
ROICexcg growth 3Y2.62%
ROICexcg growth 5Y-2.33%
ROICexc growth 3Y7.9%
ROICexc growth 5Y2.55%
OM growth 3Y9.77%
OM growth 5Y2.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.87%
GM growth 5Y1.82%
F-Score5
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Profit Quality N/A
Current Ratio 0.92
Quick Ratio 0.92
Altman-Z 0.63
F-Score5
WACC3.68%
ROIC/WACCN/A
Cap/Depr(3y)91.16%
Cap/Depr(5y)89.32%
Cap/Sales(3y)3.77%
Cap/Sales(5y)3.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
Growth
EPS 1Y-824.8%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-3989.22%
EPS Next Y-198.48%
EPS Next 2Y-76.24%
EPS Next 3Y-47.78%
EPS Next 5YN/A
Revenue growth 1Y9.33%
Revenue growth 3Y-1.25%
Revenue growth 5Y-2.63%
Revenue growth Q2Q0%
Revenue Next Year7.51%
Revenue Next 2Y8.28%
Revenue Next 3Y7.56%
Revenue Next 5YN/A
EBIT growth 1Y133.51%
EBIT growth 3Y8.39%
EBIT growth 5Y0.07%
EBIT Next Year121.31%
EBIT Next 3Y35.24%
EBIT Next 5YN/A
FCF growth 1Y-248.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-91.45%
OCF growth 3Y3.06%
OCF growth 5Y3.77%